Screener
Sarepta Therapeutics, Inc. SRPT Business Segments — Compensation And Other Personnel Expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept srpt:CompensationAndOtherPersonnelExpenses.
The source filing: Sarepta Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335003
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Total revenues | $401,251 | $611,091 | $1,132,054 | $1,355,947 |
| Segment expenses and other segment items: | ||||
| Cost of sales (excluding amortization of in-licensed rights) | 149,385 | 152,558 | 258,153 | 290,122 |
| Compensation and other personnel expenses | 60,725 | 89,839 | 122,655 | 182,923 |
| Up-front and collaboration license fees | — | — | 50,000 | 583,787 |
| Manufacturing expenses | 1,837 | 80,685 | 21,595 | 148,150 |
| Clinical trial expenses | 23,102 | 33,511 | 41,406 | 66,658 |
| Facility- and technology-related expenses (excluding depreciation and amortization) | 23,890 | 28,580 | 46,832 | 56,237 |
Item 1. Financial Statements
FAQ
- What is Sarepta Therapeutics, Inc.'s business segments — compensation and other personnel expenses?
- Sarepta Therapeutics, Inc. (SRPT) reported business segments — compensation and other personnel expenses of $60.73M in Q2 2026.
- How has Sarepta Therapeutics, Inc.'s business segments — compensation and other personnel expenses changed year-over-year?
- Sarepta Therapeutics, Inc.'s business segments — compensation and other personnel expenses decreased by 32.4% year-over-year, from $89.84M to $60.73M.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s business segments — compensation and other personnel expenses?
- Over 3 years (2022 to 2025), Sarepta Therapeutics, Inc.'s business segments — compensation and other personnel expenses has grown at a 4.8% compound annual growth rate (CAGR), from $256.38M to $294.97M.
- What does business segments — compensation and other personnel expenses mean?
- Captures the total expenditure related to employee salaries, benefits, and other personnel-related costs within the specific segment. Monitoring this helps assess the segment's operational leverage and human capital investment intensity.
Ask your AI about Sarepta Therapeutics, Inc.'s business segments — compensation and other personnel expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude